10-48446419-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021226.4(ARHGAP22):c.2069G>A(p.Gly690Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000563 in 1,614,118 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021226.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000402 AC: 101AN: 251476Hom.: 0 AF XY: 0.000478 AC XY: 65AN XY: 135914
GnomAD4 exome AF: 0.000594 AC: 869AN: 1461872Hom.: 3 Cov.: 32 AF XY: 0.000615 AC XY: 447AN XY: 727242
GnomAD4 genome AF: 0.000256 AC: 39AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2069G>A (p.G690E) alteration is located in exon 10 (coding exon 10) of the ARHGAP22 gene. This alteration results from a G to A substitution at nucleotide position 2069, causing the glycine (G) at amino acid position 690 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at